Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D BAGSHAWE

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Current Drug Targets|February 10, 2009
Targeting: the ADEPT story so farK D Bagshawe
Obstetrics and Gynecology Clinics of North America|September 1, 1988
High-risk metastatic trophoblastic diseaseK D Bagshawe
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Choriocarcinoma. A model for tumour markersK D Bagshawe
Ciba Foundation Symposium|January 1, 1983
Human chorionic gonadotropin as a model for a fetal antigenK D Bagshawe
British Journal of Cancer|September 1, 1989
The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sitesK D Bagshawe
Cell Biophysics|January 1, 1994
ADEPT and related conceptsK D Bagshawe
Lancet (London, England)|October 4, 1986
Reversed-role chemotherapy for resistant cancerK D Bagshawe
The Journal of Reproductive Medicine|November 1, 1984
Treatment of high-risk choriocarcinomaK D Bagshawe
British Journal of Cancer|August 1, 1983
Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here?K D Bagshawe
Cancer|September 1, 1976
Risk and prognostic factors in trophoblastic neoplasiaK D Bagshawe
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Current Drug Targets|February 10, 2009
Targeting: the ADEPT story so farK D Bagshawe
Obstetrics and Gynecology Clinics of North America|September 1, 1988
High-risk metastatic trophoblastic diseaseK D Bagshawe
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Choriocarcinoma. A model for tumour markersK D Bagshawe
Ciba Foundation Symposium|January 1, 1983
Human chorionic gonadotropin as a model for a fetal antigenK D Bagshawe
British Journal of Cancer|September 1, 1989
The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sitesK D Bagshawe
Cell Biophysics|January 1, 1994
ADEPT and related conceptsK D Bagshawe
Lancet (London, England)|October 4, 1986
Reversed-role chemotherapy for resistant cancerK D Bagshawe
The Journal of Reproductive Medicine|November 1, 1984
Treatment of high-risk choriocarcinomaK D Bagshawe
British Journal of Cancer|August 1, 1983
Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here?K D Bagshawe
Cancer|September 1, 1976
Risk and prognostic factors in trophoblastic neoplasiaK D Bagshawe
Pageof 18